MP41-20 DEFINING THE UTILITY OF MSK-ACCESS, A CELL-FREE TUMOR DNA ASSAY, IN PATIENTS TREATED WITH RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER